Want to see FR:LNA full AI Analyst Report?
Top Page
LNA Sante SA
(LNA)
Select Model
Select Model
Rating:61Neutral
Price Target:
€26.00
▼(-23.98% Downside)
Action:Reiterated
Date:10/03/26
Overall score reflects solid operating cash generation and supportive valuation (low P/E and high dividend yield), offset by elevated balance-sheet leverage and weak technical trend (price below key moving averages with negative MACD), which raises risk despite oversold signals.
Positive Factors
Steady revenue growth
A sustained revenue-growth record indicates ongoing demand for LNA Santé’s elderly-care and rehabilitation services. Continued expansion of the revenue base can support operating scale, reinforce facility utilization, and provide a durable foundation for cash generation over the next several quarters.
Negative Factors
Debt-heavy balance sheet
High leverage leaves LNA Santé more exposed to refinancing conditions and earnings volatility than a less indebted care operator. Debt servicing and refinancing needs can restrict capital allocation, reduce resilience during weaker trading, and limit flexibility to fund future investment internally.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady revenue growth
A sustained revenue-growth record indicates ongoing demand for LNA Santé’s elderly-care and rehabilitation services. Continued expansion of the revenue base can support operating scale, reinforce facility utilization, and provide a durable foundation for cash generation over the next several quarters.
Read all positive factors
LNA Sante SA (LNA) vs. iShares MSCI France ETF (EWQ)
Market Cap
€251.13M
Dividend Yield7.88%
Average Volume (3M)9.58K
Price to Earnings (P/E)9.8
Beta (1Y)0.45
Revenue Growth10.06%
EPS Growth21.64%
CountryFR
Employees8,777
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)2.47
Shares Outstanding10,709,416
10 Day Avg. Volume10,905
30 Day Avg. Volume9,584
Financial Highlights & Ratios
PEG Ratio1.01
Price to Book (P/B)0.76
Price to Sales (P/S)0.28
P/FCF Ratio4.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.9
Revenue Forecast (FY)€961.21M
LNA Sante SA Business Overview & Revenue Model
Company Description
Established in 1990 and headquartered in Vertou, France, LNA Santé SA specializes in the administration and operation of a diverse portfolio of healthcare facilities. These include residences for the elderly, medical and rehabilitative care center...
How the Company Makes Money
LNA primarily makes money by operating healthcare facilities and charging for patient stays and care services delivered within its network. Key revenue streams typically include: (1) fees and reimbursements linked to long-term elderly care (e.g., ...
LNA Sante SA Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
44
Neutral
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 950.25M | 912.67M | 806.60M | 736.09M | 728.22M | 689.49M |
| Gross Profit | 125.91M | 132.24M | 91.10M | 241.09M | 622.42M | 577.87M |
| EBITDA | 149.31M | 142.73M | 144.85M | 144.63M | 148.61M | 137.45M |
| Net Income | 25.34M | 24.14M | 21.82M | 23.41M | 25.81M | 23.51M |
Balance Sheet | ||||||
| Total Assets | 1.65B | 1.60B | 1.54B | 1.51B | 1.51B | 1.53B |
| Cash, Cash Equivalents and Short-Term Investments | 89.43M | 94.83M | 75.06M | 77.17M | 101.98M | 152.12M |
| Total Debt | 940.41M | 907.25M | 936.51M | 887.67M | 911.55M | 1.00B |
| Total Liabilities | 1.31B | 1.26B | 1.21B | 1.20B | 1.21B | 1.31B |
| Stockholders Equity | 333.54M | 330.25M | 313.81M | 299.24M | 289.33M | 216.09M |
Cash Flow | ||||||
| Free Cash Flow | 58.89M | 59.30M | 71.24M | 84.56M | 89.86M | 65.98M |
| Operating Cash Flow | 69.08M | 70.42M | 82.06M | 97.50M | 103.20M | 79.92M |
| Investing Cash Flow | -21.83M | -14.21M | -23.72M | -15.69M | -41.99M | -27.65M |
| Financing Cash Flow | -25.87M | -36.50M | -88.80M | -106.69M | -110.88M | -21.53M |
LNA Sante SA Technical Analysis
Negative
34.20
Price Trends
28.36
Negative
31.27
Negative
29.19
Negative
Market Momentum
-1.27
Negative
40.39
Neutral
81.48
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LNA, the sentiment is Negative. The current price of 34.2 is above the 20-day moving average (MA) of 23.57, above the 50-day MA of 28.36, and above the 200-day MA of 29.19, indicating a neutral trend. The MACD of -1.27 indicates Negative momentum. The RSI at 40.39 is Neutral, neither overbought nor oversold. The STOCH value of 81.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:LNA.
LNA Sante SA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | €327.60M | 12.55 | 6.82% | 7.22% | -1.80% | 35.22% | |
61 Neutral | €251.13M | 9.76 | 7.63% | 7.88% | 10.06% | 21.64% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | €134.70M | 2.33 | 49.70% | 0.58% | -1.79% | 10979.07% | |
51 Neutral | €1.68B | -6.36 | -15.35% | 0.84% | 3.92% | 31.20% | |
49 Neutral | €975.60M | -16.00 | -4.25% | 11.04% | 2.65% | 10.71% | |
47 Neutral | €486.67M | -2.84 | -152.15% | ― | -27.19% | -117.39% |
* General Sector Average
FR:LNA
LNA Sante SA
24.10
0.53
2.25%
FR:BLC
Bastide le Confort Medical
18.42
-6.28
-25.43%
FR:BOI
Boiron SA
18.70
-8.08
-30.17%
FR:EMEIS
Orpea SA
10.43
-3.88
-27.11%
FR:GDS
Ramsay Generale de Sante
8.84
-0.38
-4.12%
FR:VLA
Valneva
2.56
-1.48
-36.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.